Trial
NCT00112749
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
American Cancer Society, Inc.
Condition
Breast Cancer
Intervention
infliximab
Why stopped
Recruitment stopped due to slow accrual and lack of evidence of need for further continuation of protocol in inpatient setting.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31